Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
NCT00132314
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
382
Enrollment
FED
Sponsor class
Conditions
Schizoaffective Disorder
Schizophrenia
Interventions
DRUG:
IM risperidone
DRUG:
oral antipsychotic medication
Sponsor
US Department of Veterans Affairs